Our Team

Bryan Morris, MS

Director, CMC Regulatory

Bryan Morris, MS

Bryan is the Director of Regulatory CMC at GentiBio. Prior to joining GentiBio, Bryan lead the Regulatory CMC cell and gene therapy early development team at Bristol Myers Squibb (formerly Juno Therapeutics) where he also supported the approval of the Breyanzi and lead the successful submission and clearance of five CAR T cell therapy INDs.  Prior to joining Juno, Bryan held a variety of roles of increasing leadership in Regulatory Affairs at Dendreon where he supported the approval of Provenge.

Bryan obtained a BS in Biology from Pacific Lutheran University and MS in Biomedical Regulatory Affairs from the University of Washington’s School of Pharmacy.